Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8882 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.863 |
High Similarity |
NPD4628 |
Phase 3 |
0.8397 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8385 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8333 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8323 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8311 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8293 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8282 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8258 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8247 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8232 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8232 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8217 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8212 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8205 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8121 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8121 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8089 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8077 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8054 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8054 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8054 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8052 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8025 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7975 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7935 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7922 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7917 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7917 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7898 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7877 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7844 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7834 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7806 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7771 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7755 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7748 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7746 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7727 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7725 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7718 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7702 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7682 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7662 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7651 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7651 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7613 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7584 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7576 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.755 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7534 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7532 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7531 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD37 |
Approved |
0.7468 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7456 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7455 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7439 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7415 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7585 |
Approved |
0.74 |
Intermediate Similarity |
NPD3764 |
Approved |
0.74 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7391 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7386 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7377 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7371 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7357 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7351 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7351 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7347 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7343 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7329 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7321 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7308 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7305 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7244 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7241 |
Intermediate Similarity |
NPD17 |
Approved |
0.7238 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7225 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7196 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7196 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7195 |
Intermediate Similarity |
NPD6385 |
Approved |
0.719 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD1613 |
Approved |
0.719 |
Intermediate Similarity |
NPD3142 |
Approved |
0.719 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7184 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7184 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7181 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7181 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7181 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD920 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7097 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7097 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7089 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7078 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7067 |
Intermediate Similarity |
NPD1049 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7051 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7051 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.705 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD2976 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7043 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7042
|
Intermediate Similarity |
NPD5535 |
Approved |